MBD5 and colitis: Gut-specific conditional deletion of mbd3 mice showed a large increase in proliferating cells in the colon after DSS treatment compared to control animals, markedly increased susceptibility to colitis-induced tumorigenesis via c-Jun-MBD5/NuRD-AP-1 signaling.